Viral vectors for dendritic cell-based immunotherapy

Trends in Immunology

Volumn 22, Issue 2, 2001, Pages 102-107

  Jenne, Lars ^a   Schuler, Gerold ^a   Steinkasserer, Alexander ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TUMOR ANTIGEN; VIRUS ANTIGEN; VIRUS VECTOR;

ADENOVIRUS; APOPTOSIS; CELL ACTIVITY; CELL FUNCTION; DENDRITIC CELL; GENE EXPRESSION; GENETIC ENGINEERING; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; INFLUENZA VIRUS; LENTIVIRINAE; NONHUMAN; RETROVIRUS; REVIEW; TRANSGENE; VACCINIA VIRUS; VIRUS INTERFERENCE;

ADJUVANTS, IMMUNOLOGIC; CLINICAL TRIALS; DENDRITIC CELLS; GENE THERAPY; GENETIC VECTORS; HUMANS; VIRAL VACCINES;

EID: 0034913277     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(00)01813-5     Document Type: Review

References (47)

1. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability
2. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application
3. Long-term culture of human CD34(+) progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34(-) CD14(-) and a CD34(-) CD14(+) dendritic cell precursor
4. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis
5. Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
6. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids
7. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
8. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis
9. Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells
10. A comparison of gene transfer methods in human dendritic cells
11. Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes
12. Adenoviral transduction of human 'clinical grade' immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity
13. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA
14. Gene therapy with recombinant adenovirus vectors: Evaluation of the host immune response
15. Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma
16. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors
17. Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL
18. Viral mechanisms of immune evasion
19. Viral subversion of the immune system
20. From sabotage to camouflage: Viral evasion of cytotoxic T lymphocyte and natural killer ell-mediated immunity
21. Interactions of viruses with dendritic cells: A double-edged sword
22. Poxviruses as expression vectors
23. Nonreplicating vaccinia vector efficiently expresses recombinant genes
24. Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expression
25. Poxvirus as a vector to transduce human dendritic cells for immunotherapy: Abortive infection but reduced APC function
26. Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes
27. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity
28. Adenovirus vectors as recombinant viral vaccines
29. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier
30. Efficient expression of the tumor-associated antigen MAGE-3 in human dendritic cells using an avian influenza virus vector
31. Generation of influenza A viruses entirely from cloned cDNAs
32. Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro
33. Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells
34. Retrovirally transduced human dendritic cells express a normal phenotype and potent T-cell stimulatory capacity
35. Efficient retrovirus-mediated gene transfer of dendritic cells generated from CD34+ cord blood cells under serum-free conditions
36. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein
37. Dendritic cells and the control of immunity
38. Inhibition of dendritic cell maturation by herpes simplex virus
39. High efficiency adenovirus-mediated gene transfer to human dendritic cells
40. Vaccinia virus inhibits the maturation of human dendritic cells: A novel mechanism of immune evasion
41. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions
42. Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset
43. Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA
44. The role of B7 costimulation in T-cell immunity
45. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells
46. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay
47. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs